KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Tax Provisions (2016 - 2025)

Merck (MRK) has disclosed Tax Provisions for 17 consecutive years, with $457.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 7.28% to $457.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 billion, a 0.04% change, with the full-year FY2025 number at $2.8 billion, changed 0.04% from a year prior.
  • Tax Provisions was $457.0 million for Q4 2025 at Merck, down from $958.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $958.0 million in Q3 2025 to a low of -$858.0 million in Q4 2023.
  • A 5-year average of $527.8 million and a median of $549.5 million in 2022 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: surged 482.35% in 2022, then plummeted 273.33% in 2023.
  • Merck's Tax Provisions stood at $85.0 million in 2021, then soared by 482.35% to $495.0 million in 2022, then tumbled by 273.33% to -$858.0 million in 2023, then surged by 149.65% to $426.0 million in 2024, then rose by 7.28% to $457.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Tax Provisions are $457.0 million (Q4 2025), $958.0 million (Q3 2025), and $571.0 million (Q2 2025).